Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: J Trauma Acute Care Surg. 2012 Aug;73(2):408–412. doi: 10.1097/TA.0b013e31825a789b

Figure 5.

Figure 5

Suppression of NO production involves ER-α. Hepatocytes were treated as described in Fig. 1. Concentrations of ER-α ligands were 10uM E2, 10uM PTT, a selective ER-α agonist and 10uM MMP, a specific ER-α antagonist. CM= Cytokine mix of rhIL-1b plus rrIFN-g. DMSO = Vehicle used as negative control.